Welcome to LookChem.com Sign In|Join Free

CAS

  • or

32383-02-1

Post Buying Request

32383-02-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

32383-02-1 Usage

General Description

2,3-Pyridinedicarboxylic acid, dimethyl ester, 1-oxide is a chemical compound with the molecular formula C8H7NO5. It is a derivative of pyridine and is commonly used as a building block in organic synthesis. 2,3-Pyridinedicarboxylic acid, dimethyl ester, 1-oxide is a colorless solid with a high melting point and is soluble in water, methanol, and ethanol. It has applications in various industries, including pharmaceuticals, agrochemicals, and materials science. Additionally, 2,3-Pyridinedicarboxylic acid, dimethyl ester, 1-oxide has potential use as an antioxidant and as a stabilizer in polymers.

Check Digit Verification of cas no

The CAS Registry Mumber 32383-02-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,3,8 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 32383-02:
(7*3)+(6*2)+(5*3)+(4*8)+(3*3)+(2*0)+(1*2)=91
91 % 10 = 1
So 32383-02-1 is a valid CAS Registry Number.

32383-02-1Relevant articles and documents

TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

-

Paragraph 2315; 2316, (2021/02/12)

The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.

CGRP ANTAGONIST COMPOUNDS

-

Page/Page column 59; 60, (2020/12/30)

The disclosures herein relate to novel compounds of Formula (1): and salts thereof, wherein A1, A2, Q, X, R1, R2 and R3 are defined herein, and their use in treating, preventing, ameliorating, control

ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE

-

Paragraph 0686; 0689; 0690, (2017/12/31)

Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 32383-02-1